Related Experiment Videos

Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in

Gary D Slade1, Elisa M Ghezzi, Gerardo Heiss

  • 1Center for Oral and Systemic Disease, Department of Dental Ecology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA.

Insights

Periodontal disease and higher body mass index (BMI) are linked to elevated C-reactive protein (CRP) levels in middle-aged adults. This suggests a combined effect on inflammation markers, impacting cardiovascular health.

Area of Science:

  • Cardiovascular Health
  • Inflammation Markers
  • Periodontal Medicine

Background:

  • Elevated C-reactive protein (CRP) indicates systemic inflammation and cardiovascular disease risk.
  • Periodontal disease, an unrecognized infection, can trigger an acute-phase response and raise CRP levels.

Purpose of the Study:

  • To investigate the association between periodontal disease and serum CRP levels in adults.
  • To explore potential modifying factors in this relationship within the Atherosclerosis Risk in Communities study.

Main Methods:

  • Oral examinations assessed periodontal disease severity (percentage of sites with pocket depth ≥4 mm) in 5552 participants (aged 52-74).
  • Serum CRP concentrations were measured using enzyme-linked immunosorbent assay.
  • Multivariable linear regression analyzed associations, controlling for age, sex, diabetes, smoking, and NSAID use.

Main Results:

  • Individuals with extensive periodontal pockets (>30% sites with pocket depth ≥4 mm) had higher mean CRP levels (7.6 mg/L) compared to those with less extensive disease (5.7 mg/L).
  • The association between periodontal pockets and CRP was modified by body mass index (BMI).
  • A significant CRP difference was observed at lower BMIs (2-fold at BMI 20), diminishing at higher BMIs (negligible at BMI 35).

Conclusions:

  • Extensive periodontal disease and BMI are jointly associated with elevated CRP levels in healthy, middle-aged adults.
  • These findings highlight the need for integrated medical and dental evaluations to identify sources of acute-phase response.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...